To include your compound in the COVID-19 Resource Center, submit it here.

Eli Lilly management changes

On Sept. 29, Eli Lilly and Co. (NYSE:LLY) announced several managerial changes, including the promotion of SVP of Clinical and Product Development Dan Skovronsky to SVP for science and

Read the full 292 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE